About this Journal Submit a Manuscript Table of Contents
Clinical and Developmental Immunology
Volume 2013 (2013), Article ID 932318, 11 pages
http://dx.doi.org/10.1155/2013/932318
Research Article

A Full GMP Process to Select and Amplify Epitope-Specific T Lymphocytes for Adoptive Immunotherapy of Metastatic Melanoma

N. Labarriere,1,2,3 A. Fortun,1,2,3 A. Bellec,4 A. Khammari,1,2,3,5 B. Dreno,1,2,3,4,5 S. Saïagh,4 and F. Lang1,2,3

1Inserm, U892, 44000 Nantes, France
2Université de Nantes, 44000 Nantes, France
3CNRS, UMR 6299, 44000 Nantes, France
4Unit of Cell and Gene Therapy, CHU Nantes, 44000 Nantes, France
5Unit of Skin Cancer, CHU Nantes, 44000 Nantes, France

Received 18 July 2013; Revised 27 August 2013; Accepted 27 August 2013

Academic Editor: John Maher

Copyright © 2013 N. Labarriere et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

N. Labarriere, A. Fortun, A. Bellec, et al., “A Full GMP Process to Select and Amplify Epitope-Specific T Lymphocytes for Adoptive Immunotherapy of Metastatic Melanoma,” Clinical and Developmental Immunology, vol. 2013, Article ID 932318, 11 pages, 2013. doi:10.1155/2013/932318